Skip to main content
. 2016 Jul 25;26(5):e5743. doi: 10.5812/ijp.5743

Table 2. Comparison Between the Effects of the Three Types of Surfactants on Different Variables Among Neonates Receiving Surfactant After Intervention.

Variable Type of Surfactant
Survanta Alveofact Curosurf P Valuea
Duration of hospital stay (mean ± SD) (days) 15.37 ± 14.2 15.47 ± 12.5 14.35 ± 12.6 0.892
Birth weight (mean ± SD) (gr) 1829 ± 782 1815 ± 729 1873 ± 859 0.926
Gestational age (mean ± SD) (weeks) 31.56 ± 3.8 31.46 ± 3.6 31.70 ± 3.8 0.949
Ventilation time (mean ± SD) (days) 1.08 ± 1.9 1.89 ± 2.9 1.57 ± 3.7 0.765
Number of surfactant injections (mean ± SD) 1.08 ± 0.33 1.55 ± 1.12 1.06 ± 0.3 0.043
Pneumothorax 0.070
Yes 2 (16.7) 7 (58.3) 3 (25)
No 60 (39.2) 42 (27.5) 51 (33.3)
Patent ductus arteriosus 0.375
Yes 8 (29.6) 11 (40.8) 8 (29.6)
No 54 (39.1) 38 (27.5) 46 (33.4)
BPD 0.782
Yes 2 (50) 1 (25) 1 (25)
No 60 (37.3) 48 (29.8) 53 (32.9)
Intracranial hemorrhage 0.841
Yes 7 (41.2) 4 (23.5) 6 (35.3)
No 55 (37.2) 45 (30.4) 48 (32.4)
NCPAP support 0.542
Yes 51 (35.9) 43 (30.3) 48 (33.8)
No 11 (47.8) 6 (26.1) 6 (26.1)
Pulmonary hemorrhage 0.055
Yes 3 (18.6) 9 (56.4) 4 (25)
No 59 (39.6) 40 (26.8) 50 (33.6)
Retinopathy 0.298
Yes 1 (33.3) 2 (66.7) 0 (0)
No 61 (37.7) 47 (29) 54 (33.3)

aANOVA and crosstabs tests.